SCHEMBL7020098

SCHEMBL7020098

CC(=O)C(C1CCOCC1)S(=O)(=O)N1CCC(Oc2ccc(Cl)cn2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.53
FPR2 P25090 3/20 0.49
PROKR1 Q8TCW9 3/20 0.49
GPR119 Q8TDV5 3/20 0.38
TACR3 P29371 1/20 0.38
CACNB4 O00305 3/20 0.38
CACNA1A O00555 3/20 0.38
CACNA1G O43497 3/20 0.38
CACNG3 O60359 3/20 0.38
CACNA1F O60840 3/20 0.38
CACNA1H O95180 3/20 0.38
CACNB3 P54284 3/20 0.38
CACNA2D1 P54289 3/20 0.38
CACNG7 P62955 3/20 0.38
CACNA1B Q00975 3/20 0.38
CACNA1D Q01668 3/20 0.38
CACNB1 Q02641 3/20 0.38
CACNG1 Q06432 3/20 0.38
CACNB2 Q08289 3/20 0.38
CACNA1S Q13698 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7023218 0.80 MMP1 (0.53) MMP1FPR2PROKR1GPR119TACR3
SCHEMBL7018357 0.79 MMP1 (0.49) MMP1FPR2PROKR1GPR119TACR3
SCHEMBL6911913 0.79 MMP1 (0.51) MMP1FPR2PROKR1GPR119TACR3
SCHEMBL7017112 0.77 MMP2 (0.42) KMT2A
SCHEMBL940600 0.75 MMP1 (0.57) MMP1FPR2PROKR1GPR119TACR3
SCHEMBL941502 0.75 FPR2 (0.64) MMP1FPR2PROKR1GPR119TACR3
SCHEMBL942134 0.75 MMP1 (0.49) MMP1FPR2PROKR1GPR119TACR3
SCHEMBL7143720 0.75 MMP1 (0.51) MMP1FPR2PROKR1GPR119CACNB4
SCHEMBL7021130 0.74 MMP1 (0.52) MMP1FPR2PROKR1GPR119CACNB4
SCHEMBL7011537 0.74 MMP1 (0.52) MMP1FPR2PROKR1GPR119CACNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370536-A1 METALLOPROTEINASE INHIBITORS AstraZeneca AB (SE) 2003-12-17 EP disclosed
EP-1370556-A1 METALLOPROTEINASE INHIBITORS AstraZeneca AB (SE) 2003-12-17 EP disclosed
WO-2002074767-A1 METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2002-09-26 WO disclosed
WO-2002074750-A1 METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2002-09-26 WO disclosed